Cargando…
A prediction study of IL-18 and IFN-γ in glucocorticoid treatment response in infants and young children with severe Mycoplasma pneumoniae pneumonia
BACKGROUND: In infants and young children, the clinical decision to apply glucocorticoids to severe Mycoplasma pneumoniae pneumonia (SMPP) is more an empirical choice with reference to clinical symptoms, but the effect is not satisfying. We aimed to explore and identify early predictive indicators o...
Autores principales: | Zhu, Ruochen, Mao, Song, Shi, Wenjing, Wu, Liangxia, Zhang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173868/ https://www.ncbi.nlm.nih.gov/pubmed/35685073 http://dx.doi.org/10.21037/tp-22-139 |
Ejemplares similares
-
Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia
por: Chung, Hai Lee, et al.
Publicado: (2011) -
The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014) -
Regulatory CD4(+)CD25(+) T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses
por: Odeh, Adam N., et al.
Publicado: (2016) -
Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy
por: Zhu, Zhenli, et al.
Publicado: (2021) -
Mycoplasma
pneumoniae–Specific IFN-γ–Producing CD4(+) Effector-Memory T Cells Correlate with Pulmonary Disease
por: Pánisová, Elena, et al.
Publicado: (2021)